| Literature DB >> 28111566 |
Vineeta Singh1, Shafiul Haque2, Ram Niwas3, Akansha Srivastava3, Mukesh Pasupuleti3, C K M Tripathi4.
Abstract
Optimization of production medium is required to maximize the metabolite yield. This can be achieved by using a wide range of techniques from classical "one-factor-at-a-time" to modern statistical and mathematical techniques, viz. artificial neural network (ANN), genetic algorithm (GA) etc. Every technique comes with its own advantages and disadvantages, and despite drawbacks some techniques are applied to obtain best results. Use of various optimization techniques in combination also provides the desirable results. In this article an attempt has been made to review the currently used media optimization techniques applied during fermentation process of metabolite production. Comparative analysis of the merits and demerits of various conventional as well as modern optimization techniques have been done and logical selection basis for the designing of fermentation medium has been given in the present review. Overall, this review will provide the rationale for the selection of suitable optimization technique for media designing employed during the fermentation process of metabolite production.Entities:
Keywords: ANN; OFAT; RSM; genetic algorithm; media optimization
Year: 2017 PMID: 28111566 PMCID: PMC5216682 DOI: 10.3389/fmicb.2016.02087
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Schematic diagram of a systematic approach of fermentation medium designing.
Examples of some interfering and non-interfering carbon sources.
| Simple carbon | Glycerol | Interfering | Actinomycin D | Foster and Katz, | |
| Erythromycins | Sánchez et al., | ||||
| Cephalosporin | Sanchez and Demain, | ||||
| Non-interfering | Simocyclinones | Theobald et al., | |||
| Monosaccharide | Glucose | Interfering | Actinomycin | Gallo and Katz, | |
| Cephalosporin | Sanchez and Demain, | ||||
| Erythromycins | Sánchez et al., | ||||
| Penicillin | Sanchez and Demain, | ||||
| Streptomycin | Sanchez and Demain, | ||||
| Non-interfering | Bacilysin | Ozcengiz et al., | |||
| Fructose | Interfering | Penicillin | Sanchez and Demain, | ||
| Non-interfering | Actinomycin | Rokem et al., | |||
| Gentamycin | Sanchez and Demain, | ||||
| Galactose | Interfering | Penicillin | Sanchez and Demain, | ||
| Non-interfering | Actinomycin | Rokem et al., | |||
| Cephalosporin | Sanchez and Demain, | ||||
| Disaccharide | Maltose | Interfering | Bacilysin | Ozcengiz et al., | |
| Non-interfering | Gentamycin | Sanchez and Demain, | |||
| Sucrose | Interfering | Erythromycins | Rokem et al., | ||
| Penicillin | Sanchez and Demain, | ||||
| Non-interfering | Cephalosporin | Sanchez and Demain, | |||
| Lactose | Interfering | ||||
| Non-interfering | Erythromycins | Rokem et al., | |||
| Penicillin | Rokem et al., | ||||
| Mannose | Interfering | Erythromycin | Sanchez and Demain, | ||
| Streptomycin | Sánchez et al., | ||||
| Non-interfering | Kanamycin | Sanchez and Demain, | |||
| Complex | Starch | Interfering | |||
| Non-interfering | Kanamycin | Rokem et al., |
Not reported.
Examples of some interfering and non-interfering nitrogen sources.
| Inorganic | Interfering | Spiramycin | Lebrihi et al., | ||
| Cephalosporin | Sanchez and Demain, | ||||
| Erythromycin | Rokem et al., | ||||
| Streptomycin | Sanchez and Demain, | ||||
| Tetracycline | Rokem et al., | ||||
| Non-interfering | |||||
| Nitrate | Interfering | Aflatoxin | Sanchez and Demain, | ||
| Non-interfering | Rifamycin | Sanchez and Demain, | |||
| Organic | Urea | Interfering | Alternariol | ||
| Non-interfering | |||||
| Amino acids | L-alanine | Interfering | Actinomycin | Rokem et al., | |
| Bacilysin | Ozcengiz et al., | ||||
| Non-interfering | |||||
| L-arginine | Interfering | ||||
| Non interfering | Cephalosporin | Sanchez and Demain, | |||
| Gramicidin S | Bacillus brevis | Poirier and Demain, | |||
| d,l-Aspartate | Interfering | Actinomycin D | Foster and Katz, | ||
| Non-interfering | Streptothricin | Sanchez and Demain, | |||
| Leucine | Interfering | Monascus pigment | Lin and Demain, | ||
| Non-interfering | Chloramphenicol | Rokem et al., | |||
| L-isoleucine | Interfering | Actinomycin D | Foster and Katz, | ||
| Non-interfering | Spiramycin | Lebrihi et al., | |||
| DL- phalanine | Interfering | Actinomycin | Rokem et al., | ||
| Non-interfering | Chloramphenicol | Rokem et al., | |||
| L-proline | Interfering | Actinomycin D | Foster and Katz, | ||
| Non-interfering | Streptomycin | Sanchez and Demain, | |||
| Tryptophan | Interfering | Candicidin | Sanchez and Demain, | ||
| Non-interfering | Actinomycin | Foster and Katz, |
Not reported.
Figure 2Schematic representation of various techniques used in optimization studies.
Plackett-Burman design for eleven variables.
| 1 | L | H | L | L | L | H | H | H | L | H | H |
| 2 | H | L | L | L | H | H | H | L | H | H | L |
| 3 | L | L | L | H | H | H | L | H | H | L | H |
| 4 | L | L | H | H | H | L | H | H | L | H | L |
| 5 | L | H | H | H | L | H | H | L | H | L | L |
| 6 | H | H | H | L | H | H | L | H | L | L | L |
| 7 | H | H | L | H | H | L | H | L | L | L | H |
| 8 | H | L | H | H | L | H | L | L | L | H | H |
| 9 | L | H | H | L | H | L | L | L | H | H | H |
| 10 | H | H | L | H | L | L | L | H | H | H | L |
| 11 | H | L | H | L | L | L | H | H | H | L | H |
| 12 | L | L | L | L | L | L | L | L | L | L | L |
H, high conc. of the components; L, low conc. of the components; D, dummy variable.
A summary of designs and optimization techniques used for the improvement of production media in some of the published studies.
| PBD | 1.45 | Gamma interferon | Castro et al., | ||
| CCD | RSM | 8.0 | Clortetracyclin, tetracycline | Teruel et al., | |
| PBD | β-amylase, pullulanase | Reddy et al., | |||
| PBD | Xylanase | Ghanem et al., | |||
| PBD, CCD | RSM | 1.82 | Compactin | Chakravarti and Sahai, | |
| CCD | RSM | 3.7 | Poly (γ-glutamic acid) | Bacillus | Shih et al., |
| full FD | RSM | Antifungal antibiotic | Gupte and Kulkarni, | ||
| PBD, BBD | RSM | 1.4 | Chitinase | Vaidya et al., | |
| ANN, GA | 1.15 | Xylitol | Baishan et al., | ||
| Full FD | RSM | 1.30 | Antifungal antibiotic | Gupte and Kulkarni, | |
| CCD | RSM | 1.35 | Actinorhodin | Elibol, | |
| CCD | RSM | Polyaccharide | Wang et al., | ||
| OFAT | 1.82 | Polyketide antibiotic | Sujatha et al., | ||
| CCD | OFAT, RSM | 1.53, 1.32 | Eucalyptene A, xyloketal A | Xiaobo et al., | |
| PBD, CCD | ANN, GA | 1.25 | Exopolysaccharide | Desai et al., | |
| PBD, CCD | RSM | 10 | Candicidin derivatives | Mao et al., | |
| Frac FD | RSM | 2.80 | Avilamycin | Zhu et al., | |
| PBD, Full FD | RSM | Pyruvic acid | Zhang and Gao, | ||
| PBD, CCD | RSM | 8.00 | Olivanic acid. | Singh and Tripathi, | |
| PBD, CCD | RSM | 3.56 | Actinomycin D | Praveen et al., | |
| PBD, CCD | RSM | 2.37 | Heparinase | Banga and Tripathi, | |
| CCD | ANN, GA | 4.00 | ActinomycinV | Singh et al., | |
| BBD | ANN, GA | 8.30 | Nisin | Guo et al., | |
| CCD | RSM | 10.0 | Oxytetracycline | Singh et al., | |
| CCD | ANN, GA | 4.00 | Actinomycin D | Khan et al., | |
| CCD | RSM | 1.37 | Antibiotic | Wang et al., | |
| PBD, BBD | RSM | 2.61 | Milbemycin | Baoxin et al., | |
| CCD | ANN, NMDS | 1.12 | Actinomycin D | Tripathi et al., | |
| PBD, BBD | RSM | 1.78 | Antibiotic | Rajeswari et al., | |
| CCD | RSM | 1.44 | Jiean-peptide | Zhong et al., |
BBD, Box-Behnken design; CCD, Central composite design; Frac FD, Fractional factorial design; Full FD, Full factorial design; RSM, Response surface methodology; ANN, Artificial neural network; GA, Genetic algorithm; NM, Nelder-Mead Simplex; NA, Neighborhood analysis; DT, Decision Tree technique;
Not reported.
Structural comparisons of CCD (CCC (CCI), CCF) and BBD for three factors.
| 1 | −1 | −1 | −1 | 1 | −1 | −1 | −1 | 1 | −1 | −1 | 0 |
| 1 | +1 | −1 | −1 | 1 | +1 | −1 | −1 | 1 | +1 | −1 | 0 |
| 1 | −1 | +1 | −1 | 1 | −1 | +1 | −1 | 1 | −1 | +1 | 0 |
| 1 | +1 | +1 | −1 | 1 | +1 | +1 | −1 | 1 | +1 | +1 | 0 |
| 1 | −1 | −1 | +1 | 1 | −1 | −1 | +1 | 1 | −1 | 0 | −1 |
| 1 | +1 | −1 | +1 | 1 | +1 | −1 | +1 | 1 | +1 | 0 | −1 |
| 1 | −1 | +1 | +1 | 1 | −1 | +1 | +1 | 1 | −1 | 0 | +1 |
| 1 | +1 | +1 | +1 | 1 | +1 | +1 | +1 | 1 | +1 | 0 | +1 |
| 1 | −1.682 | 0 | 0 | 1 | −1 | 0 | 0 | 1 | 0 | −1 | −1 |
| 1 | 1.682 | 0 | 0 | 1 | +1 | 0 | 0 | 1 | 0 | +1 | −1 |
| 1 | 0 | −1.682 | 0 | 1 | 0 | −1 | 0 | 1 | 0 | −1 | +1 |
| 1 | 0 | 1.682 | 0 | 1 | 0 | +1 | 0 | 1 | 0 | +1 | +1 |
| 1 | 0 | 0 | −1.682 | 1 | 0 | 0 | −1 | 3 | 0 | 0 | 0 |
| 1 | 0 | 0 | 1.682 | 1 | 0 | 0 | +1 | ||||
| 6 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | ||||
| Total Runs = 20 | Total Runs = 20 | Total Runs = 15 | |||||||||
CCC, Circumcentered; CCI, Inscribed; CCF, Face centered; BBD, Box-Behnken.
Figure 3Multilayer feed forward network with one hidden layer.